We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now


It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

PTPI Petros Pharmaceuticals Inc

-0.005 (-0.37%)
Last Updated: 15:11:05
Delayed by 15 minutes


Draw Mode:

Volume 50,121
Bid Price 1.31
Ask Price 1.35
News -
Day High 1.409


52 Week Range


Day Low 1.30
Company Name Stock Ticker Symbol Market Type
Petros Pharmaceuticals Inc PTPI NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.005 -0.37% 1.335 15:11:05
Open Price Low Price High Price Close Price Prev Close
1.30 1.30 1.409 1.34
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
182 50,121 $ 1.36 $ 67,955 - 0.9172 - 9.54
Last Trade Time Type Quantity Stock Price Currency
15:11:05 100 $ 1.335 USD

Petros Pharmaceuticals Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
2.93M 2.20M - 9.38M -20.04M -9.10 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Petros Pharmaceuticals News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No PTPI Message Board. Create One! See More Posts on PTPI Message Board See More Message Board Posts

Historical PTPI Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week1.362.001.251.48533,485-0.025-1.84%
1 Month1.392.001.201.47146,877-0.055-3.96%
3 Months1.962.131.201.5578,435-0.625-31.89%
6 Months2.384.741.203.33216,091-1.05-43.91%
1 Year3.159.540.91724.73764,039-1.82-57.62%
3 Years33.0059.5990.917226.542,072,597-31.67-95.95%
5 Years18.0059.5990.917226.542,064,647-16.67-92.58%

Petros Pharmaceuticals Description

Petros Pharmaceuticals Inc is a men's health pharmaceutical company. It focuses on identifying, developing, acquiring, and commercializing innovative therapeutics for men's health issues including erectile dysfunction, peyronie's disease, hormone health and substance use disorders. The company's operating segment includes Prescription Medications and Medical Devices. It generates maximum revenue from the Prescription Medications segment. The Prescription Medications segment consists primarily of operations related to Stendra, which is sold generally in the United States, and H100 for the treatment of Peyronie's disease.

Your Recent History

Delayed Upgrade Clock

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

Support: 1-888-992-3836 |